Ban direct to consumer advertising, report recommendsBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7387.467/a (Published 01 March 2003) Cite this as: BMJ 2003;326:467
- Bob Burton
A report on direct to consumer advertising of prescription only medicines in New Zealand has recommended that the practice be banned.
The report, by senior academic staff at all four of New Zealand's medical schools, concluded that such advertising, which is allowed in New Zealand, does not give “objective information on risks, benefits and options to assist patients to participate in healthcare decisions.”
Professor Les Toop, from the University of Otago's Christchurch School of Medicine and Health Sciences, and his five colleagues recommended that “an independent health information service” be established to inform consumers on health and treatment …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial